Previous 10 | Next 10 |
Search all news topics from around the world.
2024-04-06 14:11:10 ET Read the full article on Seeking Alpha For further details see: India's Wipro names insider Srini Pallia as new CEO, succeeding Thierry Delaporte
PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation of risperidone microspheres (R064766) Additional UZEDY data include a new analysis from the Phase 3 RISE trial reinforcing its efficacy...
2024-04-06 12:45:22 ET More on Warner Music Warner Music Group Corp. (WMG) Q1 2024 Earnings Call Transcript Spotify gains as it's said to boost prices again, push audiobooks ‘Dune 2’ rakes in $81.5M for biggest movie opening of 2024 Seeking Alph...
2024-04-06 10:41:22 ET Elon Musk's xAI is in talks with investors to raise $3B in a funding round that would value the billionaire businessman's artificial intelligence startup at $18B, the Wall Street Journal reported on Friday, citing people familiar with the matter. ... ...
2024-04-06 06:00:00 ET "AWS customers are focusing on moving critical mass of data into the cloud for Gen-AI deployment long-term; and existing data in the cloud are upgraded to vectorized or unstructured data warehousing to optimize for Gen-AI," Lee noted.... Read the full article on...
New indication for this one-time infusion may provide patients with a treatment-free respite as early as first relapse Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FDA) has approved CA...
Based on three phase 2 trials of Daiichi Sankyo and AstraZeneca’s ENHERTU that showed clinically meaningful responses across a broad range of tumors ENHERTU now has five approved indications with the latest in HER2 expressing (IHC 3+) metastatic cancers Daiichi Sankyo (TSE: 4...
Based on three Phase II trials of AstraZeneca and Daiichi Sankyo’s ENHERTU which showed clinically meaningful responses across a broad range of tumors ENHERTU now has five approved indications with the latest in HER2-expressing (IHC 3+) metastatic cancers AstraZ...
Herbalife Ltd. (NYSE: HLF) (the “Company”), a premier health and wellness company, community and platform, today announced it is in the process of completing its previously announced $1.2 billion secured refinancing, which is expected to include a $400 million, 5-year senior secured...
2024-04-05 20:18:41 ET More on First Solar First Solar Remains A Viable Solar Investment, Despite The Silicon Headwinds First Solar: An Attractive Risk-Premium Ratio First Solar: Misunderstood Solar Energy Leader Set To Soar In 2024 Read the full article on...